Issue 4 - August 2010 - Pacini Editore
Issue 4 - August 2010 - Pacini Editore
Issue 4 - August 2010 - Pacini Editore
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
138<br />
agnosed as thyroid carcinoma of any type from 1979 to March<br />
2004. A total of 1039 cases was found. Representative slides<br />
from each case were selected and re-classified according to<br />
the criteria recommended by standard texts 1 2 with the addition<br />
of the categories suggested by the Chernobyl pathology<br />
group 7 . Follow-up and clinical information were obtained<br />
from the Reggio Emilia Cancer Registry and from the files of<br />
the Pathology and Endocrinology Department. Follow-up was<br />
available in 1009 cases and ranged from 4.5 to 29 years (median,<br />
9.8 years; mean, 11.9 years) or until death. Among the<br />
1009 cases, 159 patients had died; thyroid carcinoma was the<br />
cause of death for 67 of the 159 patients, and these 67 cases<br />
are the focus of the study.<br />
Results. Among the 67 patients deceased as a consequence of<br />
thyroid carcinoma, there were none of the tumors belonging to<br />
any of the categories above mentioned, that is MIFCa, FV-PTC,<br />
WDT-UMP, and FT-UMP. In fact, the vast majority of these<br />
tumors shows a shows an exceedingly innocuous behaviour<br />
following conservative surgery. The overdiagnosis of this condition<br />
may lead to excessive treatment, including total thyroidectomy<br />
followed by radioactive iodide therapy. This acquires a<br />
particular importance with the encapsulated variant of FV-PTC,<br />
which is associated with an excellent prognosis and for which<br />
distant blood-borne metastasis has been rarely documented 8 .<br />
The results of this study and a critical review of the pertinent<br />
literature indicate that tumors with these features are associated<br />
with an extremely favourable outcome and that they<br />
do not play a significant role in the fatality rate of thyroid<br />
carcinoma 9 10 .<br />
references<br />
1 DeLellis RA, Lloyd RV, Heitz PU, et al. Tumours of Endocrine Organs,<br />
World Health Organization Classification of Tumours; Pathology<br />
and Genetics. Lyon: IARC Press 2004.<br />
2 Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland,<br />
Atlas of Tumor Pathology, Third Series, Fascicle 5, Washington, D.C:<br />
Armed Forces Institute of Pathology, AFIP 1992.<br />
3 Franc B, De La Salmoniere P, Lange F, et al. Interobserver and intraobserver<br />
reproducibility in the histopathology of follicular thyroid<br />
carcinoma. Hum Pathol 2003;34:1092-100.<br />
4 Van Heerden JA, Ray ID, Goellner JR, et al. Follicular thyroid carcinoma<br />
with capsular invasion alone: a non-threatening malignancy.<br />
Surgery 1992;112:1130-8.<br />
5 Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid.<br />
A clinicopathologic study of 241 cases treated at the University<br />
of Florence, Italy. Cancer 1985;55:805-28.<br />
6 Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the<br />
diagnosis of follicular variant of papillary thyroid carcinoma. Am J<br />
Surg Pathol 2004;28:1336-40.<br />
7 Williams ED (on behalf of the Chernobyl Pathologists Group). Two<br />
proposals regarding the terminology of thyroid tumors. Intern J Surg<br />
Pathol 2000;8:181-4.<br />
8 Chan JKC. Strict criteria should be applied in the diagnosis of encapsulated<br />
follicular variant of papillary thyroid carcinoma. Am J Clin<br />
Pathol 2002;117:16-18.<br />
9 Piana S, Frasoldati A, Di Felice E et al. Encapsulated well-differentiated<br />
follicular-patterned thyroid carcinomas do not play a significant<br />
role in the fatality rates from thyroid carcinoma. Am J Surg Pathol<br />
(E-pub ahead of print).<br />
10 Rosai J. The encapsulated follicular variant of papillary thyroid carcinoma;<br />
back to the drawing board. Endocr Pathol <strong>2010</strong>;21:7-11.<br />
5 th triennial congress of the italian society of anatomic Pathology and diagnostic cytoPathology<br />
Vascular lesions of the thyroid<br />
M. Papotti, M. Volante.<br />
Department of Clinical and Biological Sciences, University of Turin<br />
at San Luigi Hospital, Orbassano (Torino), Italy<br />
Vascular lesions of the thyroid gland include benign endothelial<br />
proliferations of reactive (Masson’s “hemangioma”),<br />
benign neoplasms (cavernous hemangioma) and the rare<br />
malignant angiosarcomas. These latter occur in pure form<br />
or combined with anaplastic carcinoma (angio-sarcomatoid<br />
carcinoma).<br />
Reactive endothelial proliferations. In long standing nodular<br />
goiter, regressive changes are common, including oedema,<br />
fibrosis and calcification. Haemorrhage is an additional<br />
event, which can be associated to complete nodule infarction,<br />
followed by reparative processes such as granulation tissue<br />
and reactive endothelial hyperplasia, closely resembling<br />
intravascular papillary endothelial proliferations (Masson’s<br />
phenomenon). In these cases, intraluminal papillary projections<br />
in vascular spaces are lined by plump endothelial cells<br />
with occasional atypias possibly leading to a suspicion of<br />
malignancy. This condition may be an uncommon consequence<br />
of fine needle aspiration biopsy or the result of spontaneous<br />
intranodular haemorrhage/infarction. Completely<br />
infarcted goiter nodules are a challenge for clinicians, radiologists<br />
and pathologists: at ultrasound investigation, such<br />
nodules having prominent vascular endothelial hyperplasia<br />
are typically hyporeflecting and unhomogeneous and/or<br />
calcified, all features simulating malignancy. At light microscopy,<br />
the diagnosis of goiter may be missed (especially<br />
in fine needle aspiration cytological material) in the absence<br />
of residual micro- or macro-follicles due to haemorrhage and<br />
endothelial hyperplasia.<br />
WHAFFT. Another condition associated to vascular proliferation<br />
in the thyroid gland was described under the acronym<br />
WHAFFT, which stands for “Worrisome Histologic Alterations<br />
Following Fine needle aspiration of the Thyroid”. The<br />
alterations caused by the fine needle aspiration passages<br />
included haemorrhage,, fibrosis, calcification and worrisome<br />
lesions, like nuclear atypia, squamous metaplasia, capsular<br />
pseudoinvasion, and plump endothelial hyperplasia in vascular<br />
spaces, mimicking vascular tumors.<br />
Thyroid hemangioma. It is very rare and generally results<br />
from subsequent organization of intranodular hemorrhagic<br />
events in goiter, thus suggesting their reactive rather than<br />
neoplastic nature.<br />
Angiosarcoma and Sarcomatoid carcinoma. Thyroid angiosarcoma<br />
(or malignant hemangioendothelioma) was originally<br />
described in mountain areas and associated to endemic<br />
goiter. Grossly, a large extensively hemorrhagic mass is<br />
recognized in the presence of multinodular goiter in the<br />
surrounding parenchyma. Microscopically, elongated cells<br />
either lining vascular spaces and protruding into them, or<br />
arranged in small solid sheets are identified. Eosinophilic cytoplasm,<br />
polygonal shape, large and hyperchromatic nucleus,<br />
prominent nucleoli and numerous mitoses are typically present,<br />
with occasional intracytoplasmic lumina. Tumor cells are<br />
reactive for FVIII-related antigen, CD31, CD34 and vimentin,<br />
as well as for cytokeratin (focally). The histogenesis of<br />
thyroid angiosarcomas is controversial being the hypothesis<br />
that all such tumors are indeed (angio)sarcomatoid anaplastic<br />
carcinomas contrasted by the alternative evidence on the<br />
existence of rare true angiosarcoma cases of the thyroid.<br />
Whether reactive endothelial hyperplasia in long standing